Tasso, maker of a gadget for at-property blood selection, has raised $100 million in Sequence B funding.

The round was led by RA Capital Management, with participation from the D.E. Shaw group, Senvest, InCube, SVB Innovation Fund, Foresite Money, Hambrecht Ducera Growth Ventures, J2V, Cedars-Sinai and Merck GHIF.

The hottest funding builds on a $17 million Series A from last calendar year and a $6.1 million round in 2019. The business strategies to use the inflow of money to create up its producing and operations to satisfy desire for its blood collection units. 

“With the COVID-19 pandemic, there has been a elementary change in how we assume about healthcare, and desire for patient-centric, in-home methods is greater than ever,” Tasso CEO and cofounder Ben Casavant said in a statement.

“Today, Tasso products are successfully supporting decentralized scientific trials, medical study and remote individual overall health monitoring. This funding spherical validates the results of our endeavours to date, and will maximize streamlined obtain to property diagnostics for anyone in the foreseeable future.”

Body weight loss startup Found also scooped up $100 million in Sequence B funding, bringing its valuation to $600 million, according to TechCrunch

The round was led by WestCap, with participation from IVP, the Chernin Group, G9 Ventures and Capable Partners, together with existing and angel investors. 

The organization emerged from stealth previously this year, saying it had raised $32 million due to the fact its start in 2020. That funding was created up of a $24 million Series A and an $8 million seed round.

Properly Dot, a electronic health and fitness system that takes advantage of AI to motivate consumers to attain targets and navigate their added benefits, lifted $70 million in a Series B round led by Valeas Money Associates.

In 2020, the organization scooped up $40 million in Sequence A funding, and it elevated $25 million in seed funding in 2019. The business options to use Series B to scale functions and make improvements to its system.

Electronic dental care firm Overjet scored $42.5 million in a Series B funding round led by Basic Catalyst and Perception Associates. 

The round, which also bundled participation from existing investors Crosslink Money and E14 Fund, provides the company’s valuation to $425 million. It comes just months immediately after Overjet lifted $27 million in Series A funding, clocking in the dental-well being startup’s overall funding at almost $80 million.

“Overjet’s slicing-edge computer software has witnessed remarkable demand from customers from clinicians and insurers alike who see our dental AI as a transformational technological innovation to advance client oral health care,” CEO and cofounder Wardah Inam said in a assertion.

“The new funding will accelerate our next chapter of growth to assist our prospects, develop the workforce and spend in the subsequent generation of technological innovation to aid client care.”

AI-backed fertility counseling company Univfy raised $6 million in a Collection B spherical led by  a portfolio organization of Atlantic Street Cash.

The company lifted a further $6 million in Sequence A funding in 2018. It designs to use the new funds to supply its system to businesses and health and fitness options as a reward for knowledge the success of likely fertility procedure and its expenses. 

“We are incredibly thrilled to be doing the job with Univfy, whose eyesight to aid fertility centers achieve better scientific results aligns with ours,” Ashish Shetty, principal of Atlantic Avenue Capital, claimed in a statement.

“Univfy is the leader in working with AI/ML to enhance fertility patients’ knowledge and increase each and every patient’s prospects of obtaining a newborn with fertility cure. We are honored to be a companion in serving to to provide the gains of Univfy’s AI/ML technologies to a lot more sufferers and providers.”

Marigold Wellness, which features an AI-supported peer aid chat for people today with compound abuse conditions and other mental health and fitness problems, raised $3.5 million in seed funding.

The spherical included investments from Tau Ventures, KdT, Epsilon, Flare and Felicis.

“The electrical power to peer product indicates Marigold relies on purely natural language processing (NLP) to realize intent. They also depend on two main channels: bulk outreach via payers (insurers) and outpatient referrals through area suppliers (health professionals),” Tau Ventures controlling companion Amit Garg wrote on LinkedIn

“The company’s eyesight is that, by stopping or minimizing habit at a population amount, they can significantly save charges, to the stage of 20x, and naturally make improvements to people’s life.”